Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Prior Therapy With Nilotinib or Dasatinib on the Outcome After Allogeneic Stem Cell Transplantation for Patients With Chronic Myeloid Leukaemia

NCT02222272 is registered in ClinicalTrials.gov with European Society for Blood and Marrow Transplantation as lead sponsor.

NCT NCT02222272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02222272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Prior Therapy With Nilotinib or Dasatinib on the Outcome After Allogeneic Stem Cell Transplantation for Patients With Chronic Myeloid Leukaemia
Lead sponsor
European Society for Blood and Marrow Transplantation
Phase
Observational
Overall status
Completed
Start date
January 1, 2010
Completion date
September 29, 2017
Enrollment
432 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

myeloid leukemia, chronic